Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts.

T Suzuki1, H Sasaki, H J Kuh

  • 1Pharmacology Division, National Cancer Center Research Institute, Tokyo, Japan.

Gene
|March 18, 2000
PubMed
Summary

Researchers determined the amino-terminal structure of the MRP5 gene, revealing high conservation between human and mouse MRP5. A splicing variant, SMRP mRNA, suggests a potential physiological role for a short MRP5 protein.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The transport of a hepatoprotective agent, isopropryl 2-(1-3-dithiethane-2-ylidene)-2[N-(4-methyl-thiazole-2-yl) carbamoyl] acetate (YH439), across Caco-2 cell monolayers.

Archives of pharmacal research·2002
Same author

A computational model for quantitative analysis of cell cycle arrest and its contribution to overall growth inhibition by anticancer agents.

Japanese journal of cancer research : Gann·2000
Same author

Computational model of intracellular pharmacokinetics of paclitaxel.

The Journal of pharmacology and experimental therapeutics·2000
Same author

Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01.

Investigational new drugs·2000
Same author

Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells.

International journal of cancer·2000
Same author

Determinants of paclitaxel penetration and accumulation in human solid tumor.

The Journal of pharmacology and experimental therapeutics·1999

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Multidrug resistance in tumors involves efflux transporters like the MRP family.
  • The amino-terminal structure of MRP5, a key transporter, remains uncharacterized.

Purpose of the Study:

  • To elucidate the amino-terminal structure of a major MRP5 transcript.
  • To determine the transcriptional start site of the MRP5 gene.
  • To compare human MRP5 and mouse mrp5 structures.

Main Methods:

  • Primer extension analysis was used to identify the major transcriptional start site.
  • Comparative sequence analysis was performed on human MRP5 and mouse mrp5.

Main Results:

  • The amino-terminal structures of human MRP5 and mouse mrp5 were successfully determined.

Related Experiment Videos

  • Human MRP5 (1437 amino acids) and mouse mrp5 (1436 amino acids) showed high sequence conservation (94.1%).
  • The SMRP mRNA was identified as a splicing variant of the MRP5 gene, expressed in various human tissues.

    • Conclusions:

    • The study provides the refined amino-terminal structure of MRP5.
    • High conservation suggests conserved function between human and mouse MRP5.
    • The SMRP mRNA variant indicates a potential physiological role for a short MRP5 protein isoform.